Joseph Surber
Impact in
-
- Antibiotic Resistance in Bacteria
-
- Bacterial Identification and Susceptibility Testing
Papers in
-
- Antimicrobial Resistance in Staphylococcus 1
- SARS-CoV-2 and COVID-19 Research 1
- SARS-CoV-2 detection and testing 1
- COVID-19 Clinical Research Studies 1
- Antifungal resistance and susceptibility 1
-
- Drug-Induced Adverse Reactions 1
- Co-authors
- Philippe Prokocimer (1 shared paper)P. Mehra (1 shared paper)Jürgen B. Bulitta (1 shared paper)G. Ralph Corey (1 shared paper)Paul Bien (1 shared paper)Jiejun Du (1 shared paper)Josephine M. Norquist (1 shared paper)Angela Williams‐Diaz (1 shared paper)
- Journals
- Clinical Infectious Diseases (1 paper)Antimicrobial Agents and Chemotherapy (1 paper)Archives of Otolaryngology - Head and Neck Surgery (1 paper)
- Partner nations
- United StatesUnited KingdomGuatemala
In The Last Decade
Joseph Surber
3 papers receiving 100 citations
Peers
Comparison fields: 5 of 38
- Molecular Medicine 26
- Clinical Biochemistry 31
- Infectious Diseases 80
- Applied Microbiology and Biotechnology 6
- Pharmacology 37
Countries citing papers authored by Joseph Surber
This map shows the geographic impact of Joseph Surber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph Surber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph Surber more than expected).
Fields of papers citing papers by Joseph Surber
This network shows the impact of papers produced by Joseph Surber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph Surber. The network helps show where Joseph Surber may publish in the future.
Co-authors
The 19 scholars most cited alongside Joseph Surber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 97 | |
| 2 | 2023 | 9 | |
| 3 | 1956 | 2 |
About Joseph Surber
Joseph Surber is a scholar working on Infectious Diseases, Pharmacology, Otorhinolaryngology, Periodontics and Organic Chemistry, having authored 3 papers that have together received 108 indexed citations. Recurring topics across this work include Oral Health Pathology and Treatment (1 paper), Antimicrobial Resistance in Staphylococcus (1 paper), SARS-CoV-2 and COVID-19 Research (1 paper), SARS-CoV-2 detection and testing (1 paper), COVID-19 Clinical Research Studies (1 paper), Drug-Induced Adverse Reactions (1 paper), Antifungal resistance and susceptibility (1 paper) and Sinusitis and nasal conditions (1 paper). The work is most often cited by research in Molecular Medicine (26 citations), Clinical Biochemistry (31 citations), Infectious Diseases (80 citations), Applied Microbiology and Biotechnology (6 citations) and Pharmacology (37 citations). Joseph Surber has collaborated with scholars based in United States, United Kingdom and Guatemala. Frequent co-authors include Philippe Prokocimer, P. Mehra, Jürgen B. Bulitta, G. Ralph Corey, Paul Bien, Jiejun Du, Josephine M. Norquist, Angela Williams‐Diaz, Matthew G. Johnson and Roman S. Kozlov. Their work appears in journals such as Clinical Infectious Diseases, Antimicrobial Agents and Chemotherapy and Archives of Otolaryngology - Head and Neck Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.